| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.13B | 61.13B | 61.49B | 59.14B | 57.08B | 51.78B |
| Gross Profit | 12.30B | 12.03B | 11.59B | 10.39B | 9.97B | 9.04B |
| EBITDA | 6.84B | 6.90B | 6.30B | 5.32B | 4.81B | 3.99B |
| Net Income | 3.16B | 3.30B | 3.17B | 2.47B | 2.18B | 1.60B |
Balance Sheet | ||||||
| Total Assets | 63.65B | 64.55B | 64.71B | 57.77B | 56.98B | 54.88B |
| Cash, Cash Equivalents and Short-Term Investments | 11.06B | 12.19B | 12.44B | 9.73B | 8.69B | 8.43B |
| Total Debt | 5.38B | 5.87B | 10.57B | 10.71B | 6.34B | 6.37B |
| Total Liabilities | 22.72B | 23.38B | 24.25B | 22.65B | 23.46B | 24.14B |
| Stockholders Equity | 39.01B | 39.21B | 38.67B | 33.45B | 31.97B | 29.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.16B | 4.96B | 3.57B | 1.28B | 2.75B |
| Operating Cash Flow | 0.00 | 4.84B | 5.54B | 4.49B | 2.03B | 3.25B |
| Investing Cash Flow | 0.00 | -1.04B | -219.00M | -1.17B | -613.00M | -409.00M |
| Financing Cash Flow | 0.00 | -4.68B | -2.83B | -2.53B | -1.58B | -928.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.43B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
74 Outperform | ¥42.47B | 7.35 | ― | 3.83% | -1.58% | 5.54% | |
66 Neutral | ¥70.38B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥39.90B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥18.56B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥6.27B | 19.21 | ― | 2.29% | 0.08% | 105.25% |